Design and Synthesis of Novel PEG-conjugated 20(S)-Camptothecin Sulfonylamidine Derivatives with Potent in Vitro Antitumor Activity Via Cu-catalyzed Three-Component Reaction

Zi-Long Song,Hai-Le Chen,Yu-Han Wang,Masuo Goto,Wen-Jing Gao,Pi-Le Cheng,Susan L. Morris-Natschke,Ying-Qian Liu,Gao-Xiang Zhu,Mei-Juan Wang,Kuo-Hsiung Lee
DOI: https://doi.org/10.1016/j.bmcl.2015.04.060
IF: 2.94
2015-01-01
Bioorganic & Medicinal Chemistry Letters
Abstract:In our continuing search for camptothecin (CPT)-derived antitumor drugs, novel structurally diverse PEG-based 20(S)-CPT sulfonylamidine derivatives were designed, synthesized via a Cu-multicomponent reaction (MCR), and evaluated for cytotoxicity against four human tumor cell lines (A-549, MDA-MB-231, KB, and KBvin). All of the derivatives showed promising in vitro cytotoxic activity against the tested tumor cell lines, and were more potent than irinotecan. Significantly, these derivatives exhibited comparable cytotoxicity against KBvin, while irinotecan was less active against this cell line. With a concise efficient synthesis and potent cytotoxic profiles, especially significant activity towards KBvin, these compounds merit further development as a new generation of CPT-derived PEG-conjugated drug candidates.
What problem does this paper attempt to address?